(Q39385860)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

1 reference

Joanna Klubo-Gwiezdzinska

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Kirk Jensen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

John Costello

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Aneeta Patel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Victoria Hoperia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Andrew Bauer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Kenneth D Burman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Leonard Wartofsky

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Vasyl Vasko

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

24 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

published in

Endocrine-Related Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

447-456

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22389381%20AND%20SRC:MED&resulttype=core&format=json

Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma.

25 January 2020

cites work

1 reference

12 December 2020

Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study.

1 reference

12 December 2020

Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease

1 reference

12 December 2020

Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion

1 reference

12 December 2020

Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.

1 reference

12 December 2020

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

1 reference

12 December 2020

Ras, PI(3)K and mTOR signalling controls tumour cell growth

1 reference

12 December 2020

Targeting RET for thyroid cancer therapy

1 reference

12 December 2020

Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.

1 reference

12 December 2020

Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents

1 reference

12 December 2020

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

1 reference

12 December 2020

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

1 reference

12 December 2020

Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer

1 reference

12 December 2020

Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?

1 reference

12 December 2020

Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience

1 reference

12 December 2020

Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients

1 reference

12 December 2020

Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena

1 reference

12 December 2020

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.

1 reference

12 December 2020

Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1.

1 reference

12 December 2020

The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells

1 reference

12 December 2020

TOR signaling in growth and metabolism

1 reference

12 December 2020

Defining the role of mTOR in cancer

1 reference

12 December 2020

Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine

1 reference

12 December 2020

KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity

1 reference

12 December 2020

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.

1 reference

12 December 2020

Inhibition of cyclin-dependent kinases by purine analogues.

1 reference

12 December 2020

Active N-Ras and B-Raf inhibit anoikis by downregulating Bim expression in melanocytic cells.

1 reference

12 December 2020

The mRNA 5' cap-binding protein eIF4E and control of cell growth

1 reference

12 December 2020

LKB1 and AMP-activated protein kinase control of mTOR signalling and growth

1 reference

12 December 2020

RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors

1 reference

12 December 2020

Inhibition of gap junction transfer sensitizes thyroid cancer cells to anoikis

1 reference

12 December 2020

AMPK as a metabolic tumor suppressor: control of metabolism and cell growth

1 reference

12 December 2020

Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway.

1 reference

12 December 2020

Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt.

1 reference

12 December 2020

Acute Metformin Overdose: Examining Serum pH, Lactate Level, and Metformin Concentrations in Survivors Versus Nonsurvivors: A Systematic Review of the Literature

1 reference

12 December 2020